Nutritional IV Therapy

Our unique IV’s can help everything from migraine relief to chronic fatigue by quickly, effectively supplying your cells with the vitamins, minerals, and amino acids they need.

Learn More

Why Nutritional IV Therapy?

Nutrient IV therapy can be beneficial for those with medical conditions as well as individuals looking to improve their general health and wellness. When nutrients are given intravenously (through an IV), nearly 100% of those nutrients are available to your tissues and cells via your bloodstream.

This allows for optimal absorption, something that is not attainable with oral supplements due to the loss during digestion. IVs also get nutrients to your tissues at a much quicker rate than other forms of nutrient supplementation. This combination of quick and maximum absorption makes IV therapy one of the most effective ways to combat nutrient deficiencies and imbalances in your body.

Nutritional IV Quickest Nutrients

Quickest, most effective way to supply your cells with the nutrients they need

Nutritional IV Customizable Nutrients

Customized nutrient add-ons to target your specific health concerns

Nutritional IV Detoxification

Detoxifies, boosts energy, relieves stress, and so much more

Request a FREE Evaluation:

    Who can Nutritional IV Therapy Help?

    Our IV’s have been shown to aid in the healing process of many conditions such as neurological disease, cardiovascular disease, joint and muscle pain and many more. They also have proven benefits for general health and wellness(1-5)! See the individual IV descriptions for details on which conditions our IVs can help improve.

    Nutritional IV Packages

    What are the Benefits of Nutritional IV Therapy?

    Our nutrient IVs contain powerful combinations of nutrients that result in the benefits below. These benefits boost general feelings of wellbeing while simultaneously improving the symptoms of countless medical conditions.

    • Boost Energy
    • Boost Immunity & Treat Autoimmunity
    • Decrease Pain & Inflammation
    • Detoxification
    • Improve Brain Function & Mental Clarity
    • Relieve Stress & Anxiety
    • Cold & Flu Remedy
    • Support Athletic Performance & Recovery
    • Hydration
    • Migraine Relief
    • Improve Overall Well-being

    Frequently Asked Questions About Nutritional IV Therapy

    Is Nutrient IV Therapy safe?

    Nutrient IV Therapy is very safe. At Extivita, we use reputable and accredited compounding pharmacies for all of our IV components. Additionally, all IV bags and tubing are DEHP-free. Our experienced, licensed staff follow all standard safety protocols and procedures to minimize the risk of infection.

    Are there any side effects to Nutrient IV Therapy?

    Side effects from Nutrient IV Therapy rarely occur, if at all. If they do, they are typically minor and temporary. Bruising or bleeding at IV site, warming or cooling sensation in arm, chest, or stomach have been reported. Our staff are trained to manage all side effects that may occur.

    How do I get started with Nutrient IV Therapy?
    • New Patients: If you are a new patient and would like to receive nutrient IV’s, you will need to register as a patient on our website. You will then be given access to the patient portal, where you will fill in your medical history. Next step is to call (919) 354-3775 and schedule a consultation with our nurse practitioner. During this consult, we will review your current medical history and discuss how this therapy can be beneficial for you. We may require certain lab work prior to receiving nutrient IV therapy.
    • Existing Patients: If you have already had a consultation for hyperbaric oxygen therapy, you will simply need a short consultation with our nurse practitioner to discuss how this therapy can be beneficial for you. There is no IV consultation charge for existing patients.
    Do I need a prescription for Nutrient IV Therapy?
    No, you do not need a prescription for intravenous vitamins and minerals.
    What happens after the IV Consultation?

    After meeting with our provider and determining which Nutrient IV Therapies will optimize your health, you simply need to schedule your infusion at the front desk. That’s it!

    Do I need to prepare for my infusion?
    • We recommend that you come in hydrated (that you drank at least 2 glasses of water) prior to your appointment. This is even more important if you drink coffee as coffee can be a diuretic. Hydrated veins are easier to access!
    • If you are coming in for an NAD+ infusion, please make sure to bring a snack because these infusions are 2-4 hours long. You might get hungry!
    What should I expect during my infusion?
    At the beginning of your appointment, you will have your vital signs taken. After all consents are checked and signed, one of our nurses will start your IV. During the infusion, vitamins, and nutrients will slowly drip from the IV line and enter your bloodstream. Feel free to sit back and relax, read, or do any stationary activity during your infusion. Depending on the type of infusion, this may take anywhere from 20 minutes to 4 hours.
    How often will I need treatments?
    The frequency of you IVs depends on your condition and personal needs. This will be discussed during your consultation.
    How soon will I feel the effects?
    Most of our patients report feeling the effects of the Nutrient IV immediately or within several hours following the infusion. Again, this will depend on the individual.
    Can I still take my medications while getting Nutrient IV Therapy?
    There are only a few medications that considered contraindications with Nutrient IV Therapy. We will review your medical history and medication list during your consultation to ensure that Nutrient IV Therapy is appropriate and safe for you.

    Recent IV Therapy News & Research

    References
    1. Nielsen, Forrest H. “Effects of Magnesium Depletion on Inflammation in Chronic Disease.” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 6, Nov. 2014, pp. 525–30. PubMed, doi:10.1097/MCO.0000000000000093.
    2. Kennedy, David O., et al. “Effects of High-Dose B Vitamin Complex with Vitamin C and Minerals on Subjective Mood and Performance in Healthy Males.” Psychopharmacology, vol. 211, no. 1, July 2010, pp. 55–68. PubMed Central, doi:10.1007/s00213-010-1870-3.
    3. Lewis, John E., et al. “The Effect of Methylated Vitamin B Complex on Depressive and Anxiety Symptoms and Quality of Life in Adults with Depression.” ISRN Psychiatry, vol. 2013, Jan. 2013. PubMed Central, doi:10.1155/2013/621453.
    4. Goodwin, J. S., et al. “Association between Nutritional Status and Cognitive Functioning in a Healthy Elderly Population.” JAMA, vol. 249, no. 21, June 1983, pp. 2917–21.
    5. Franco, R., et al. “The Central Role of Glutathione in the Pathophysiology of Human Diseases.” Archives of Physiology & Biochemistry, vol. 113, no. 4/5, Taylor & Francis Ltd, Oct. 2007, pp. 234–58. EBSCOhost, doi:10.1080/13813450701661198.
    6. Wang, Fong, et al. “Oral Magnesium Oxide Prophylaxis of Frequent Migrainous Headache in Children: A Randomized, Double-Blind, Placebo-Controlled Trial.” Headache, vol. 43, no. 6, June 2003, pp. 601–10. PubMed, doi:10.1046/j.1526-4610.2003.03102.x.
    7. von Luckner, Alexander, and Franz Riederer. “Magnesium in Migraine Prophylaxis—Is There an Evidence‐Based Rationale? A Systematic Review.” Headache: The Journal of Head and Face Pain, vol. 58, no. 2, Wiley Subscription Services, Inc, 2018, pp. 199–209. wfu.primo.exlibrisgroup.com, doi:10.1111/head.13217.
    8. Office of Dietary Supplements – Calcium. https://ods.od.nih.gov/factsheets/Calcium-Consumer/. Accessed 18 Aug. 2020.
    9. Tarleton, Emily K., and Benjamin Littenberg. “Magnesium Intake and Depression in Adults.” Journal of the American Board of Family Medicine: JABFM, vol. 28, no. 2, Apr. 2015, pp. 249–56. PubMed, doi:10.3122/jabfm.2015.02.140176.
    10. Rajizadeh, Afsaneh, et al. “Effect of Magnesium Supplementation on Depression Status in Depressed Patients with Magnesium Deficiency: A Randomized, Double-Blind, Placebo-Controlled Trial.” Nutrition, vol. 35, Elsevier BV, Elsevier Inc, Elsevier BV, Elsevier Limited, 2017, pp. 56–60. wfu.primo.exlibrisgroup.com, doi:10.1016/j.nut.2016.10.014.
    11. Saedisomeolia, Ahmad, and Marziyeh Ashoori. “Riboflavin in Human Health: A Review of Current Evidences.” Advances in Food and Nutrition Research, vol. 83, 2018, pp. 57–81. PubMed, doi:10.1016/bs.afnr.2017.11.002.
    12. Kennedy, David. “B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review.” Nutrients, vol. 8, no. 2, MDPI AG, MDPI, 2016, pp. 68–68. wfu.primo.exlibrisgroup.com, doi:10.3390/nu8020068.
    13. O’Leary, Fiona, and Samir Samman. “Vitamin B12 in Health and Disease.” Nutrients, vol. 2, no. 3, Mar. 2010, pp. 299–316. PubMed Central, doi:10.3390/nu2030299.
    14. Braidy, Nady et al. “Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.” Antioxidants & redox signaling vol. 30,2 (2019): 251-294. doi:10.1089/ars.2017.7269
    15. Yoshino, Jun, et al. “NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR.” Cell Metabolism, vol. 27, no. 3, Mar. 2018, pp. 513–28. PubMed, doi:10.1016/j.cmet.2017.11.002. 
    16. Camacho-Pereira, Juliana, et al. “CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.” Cell Metabolism, vol. 23, no. 6, June 2016, pp. 1127–39. PubMed, doi:10.1016/j.cmet.2016.05.006. 
    17. Imai, Shin-ichiro, and Leonard Guarente. “NAD+ and Sirtuins in Aging and Disease.” Trends in Cell Biology, vol. 24, no. 8, Aug. 2014, pp. 464–71. PubMed, doi:10.1016/j.tcb.2014.04.002. 
    18. Hikosaka, Keisuke, et al. “Deficiency of Nicotinamide Mononucleotide Adenylyltransferase 3 (Nmnat3) Causes Hemolytic Anemia by Altering the Glycolytic Flow in Mature Erythrocytes.” The Journal of Biological Chemistry, vol. 289, no. 21, May 2014, pp. 14796–811. PubMed, doi:10.1074/jbc.M114.554378. 
    19. Fang, Evandro F., et al. “NAD+ in Aging: Molecular Mechanisms and Translational Implications.” Trends in Molecular Medicine, vol. 23, no. 10, Oct. 2017, pp. 899–916. PubMed, doi:10.1016/j.molmed.2017.08.001. 
    20. Lutz, Mirjam I., et al. “Distinct Patterns of Sirtuin Expression during Progression of Alzheimer’s Disease.” Neuromolecular Medicine, vol. 16, no. 2, June 2014, pp. 405–14. PubMed, doi:10.1007/s12017-014-8288-8. 
    21. Qin, Weiping, et al. “Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction.” The Journal of Biological Chemistry, vol. 281, no. 31, Aug. 2006, pp. 21745–54. PubMed, doi:10.1074/jbc.M602909200. 
    22. Brandes, Ralf P. “Activating SIRT1: A New Strategy to Prevent Atherosclerosis?” Cardiovascular Research, vol. 80, no. 2, Nov. 2008, pp. 163–64. PubMed, doi:10.1093/cvr/cvn245. 
    23. Yu, Wei, et al. “SIRT1: A Novel Target to Prevent Atherosclerosis.” Journal of Cellular Biochemistry, vol. 108, no. 1, Sept. 2009, pp. 10–13. PubMed, doi:10.1002/jcb.22240. 
    24. de Picciotto, Natalie E., et al. “Nicotinamide Mononucleotide Supplementation Reverses Vascular Dysfunction and Oxidative Stress with Aging in Mice.” Aging Cell, vol. 15, no. 3, June 2016, pp. 522–30. PubMed, doi:10.1111/acel.12461.
    25. Miller, R et al. “COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity.” Medical hypotheses vol. 144 (2020): 110044. doi:10.1016/j.mehy.2020.110044
    26. Pfluger, Paul T., et al. “Sirt1 Protects against High-Fat Diet-Induced Metabolic Damage.” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 28, July 2008, pp. 9793–98. PubMed, doi:10.1073/pnas.0802917105.
    27. Johnson, Sean, and Shin-ichiro Imai. “NAD + Biosynthesis, Aging, and Disease.” F1000Research, vol. 7, Feb. 2018. PubMed Central, doi:10.12688/f1000research.12120.1.
    28. Grant, Ross et al. “A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD.” Frontiers in aging neuroscience vol. 11 257. 12 Sep. 2019, doi:10.3389/fnagi.2019.00257
    29. Deponte, Marcel. “The Incomplete Glutathione Puzzle: Just Guessing at Numbers and Figures?” Antioxidants & Redox Signaling, vol. 27, no. 15, Nov. 2017, pp. 1130–61. PubMed Central, doi:10.1089/ars.2017.7123.
    30. Alpert, Michelle. “The Diverse Benefits of Glutathione: A Key Antioxidant for Reversing Chronic Illness.” Alternative and Complementary Therapies, vol. 11, no. 5, Oct. 2005, pp. 241–45. DOI.org (Crossref), doi:10.1089/act.2005.11.241.
    31. Pizzorno, Joseph. “Glutathione!” Integrative Medicine: A Clinician’s Journal, vol. 13, no. 1, Feb. 2014, pp. 8–12.
    32. Sadeghi, Omid, et al. “Effects of Pyridoxine Supplementation on Severity, Frequency and Duration of Migraine Attacks in Migraine Patients with Aura: A Double-Blind Randomized Clinical Trial Study in Iran.” Iranian Journal of Neurology, vol. 14, no. 2, Apr. 2015, pp. 74–80.
    33. Ishmael, Faoud T. “The Inflammatory Response in the Pathogenesis of Asthma.” The Journal of the American Osteopathic Association, vol. 111, no. 11_suppl_7, American Osteopathic Association, Nov. 2011, pp. S11–17.
    34. Hemilä, Harri. “Vitamin C and Asthma.” Journal of Allergy and Clinical Immunology, vol. 134, no. 5, Elsevier, Nov. 2014, p. 1216. www.jacionline.org, doi:10.1016/j.jaci.2014.08.032.
    35. Moreno-Macias, Hortensia, and Isabelle Romieu. “Effects of Antioxidant Supplements and Nutrients on Patients with Asthma and Allergies.” Journal of Allergy and Clinical Immunology, vol. 133, no. 5, May 2014, pp. 1237–44. DOI.org (Crossref), doi:10.1016/j.jaci.2014.03.020.
    36. Wood, Lisa G., et al. “Manipulating Antioxidant Intake in Asthma: A Randomized Controlled Trial.” The American Journal of Clinical Nutrition, vol. 96, no. 3, Oxford Academic, Sept. 2012, pp. 534–43. academic.oup.com, doi:10.3945/ajcn.111.032623.
    37. Statovci, Donjete, et al. “The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces.” Frontiers in Immunology, vol. 8, Frontiers, 2017. Frontiers, doi:10.3389/fimmu.2017.00838.
    38. Thuesen, B. H., et al. “Atopy, Asthma, and Lung Function in Relation to Folate and Vitamin B(12) in Adults.” Allergy, vol. 65, no. 11, Nov. 2010, pp. 1446–54. PubMed, doi:10.1111/j.1398-9995.2010.02378.x.
    39. Shrader, Welman A. “Short and Long Term Treatment of Asthma with Intravenous Nutrients.” Nutrition Journal, vol. 3, May 2004, p. 6. PubMed Central, doi:10.1186/1475-2891-3-6.
    40. Popa, Calin, et al. “The Role of TNF-Alpha in Chronic Inflammatory Conditions, Intermediary Metabolism, and Cardiovascular Risk.” Journal of Lipid Research, vol. 48, no. 4, Apr. 2007, pp. 751–62. PubMed, doi:10.1194/jlr.R600021-JLR200.
    41. Ellis, Mary. “Intravenous Rehydration | Definition and Patient Education.” Healthline, 17 Sept. 2018, https://www.healthline.com/health/intravenous-rehydration.